SandiaBio News Page

February 2023— Superfolder GFP & Split GFP - Sandia Biotech - Protein Folding Assay - Protein Analysis webinar .

June 2022—Attended BIO International 2022  with the New Mexico Pavilion to showcase innovative FluorAbody technology joint with Etaluma (a California company who has commercialized a state-of-the-art digital microscope platform).

April 2021–Collaborated withSciVista (Virtual reality company) and Los Alamos National Laboratory in leverage project.

January 2021— “Systemic Creation of Fluorescent Fusion Polypeptides” Patent granted.

January 2021 – FluorAbodies are tested in live-cell imaging with  Confocal.nl’s Re-scan Confocal Microscope Technology Platform. Look at our anti-Her2-RFP FluorAbody in action here.

April 2019 – NMSBA assistantship through Sandia National Laboratories

March 2017– NMSBA assistantship through Sandia National Laboratories

March 2016 – NMSBA assistantship through Sandia National Laboratories

February 2016 – Purchased the assets of Azano Scientific which includes a license to G protein estrogen receptor (GPER) compounds from STC.UNM and NMSU.

May 2015 – Entered agreement with Funakoshi of Japan as a distributor for Asia-Pacific.

October 2015 – Entered into a world-wide exclusive license agreement with STC.UNM which leads to the further development of an efficient and proprietary manufacturing process of FluorAbody® technology ( fluorescent antibody analogues) with intellectual property covered by several patents.

February 2015 – Entered into a co-distribution agreement with Azano Pharmaceuticals, Inc. of Albuquerque, NM.

September 2013 – Entered into a global distribution agreement with Sigma-Aldrich for Sandia Biotech’s Split Green Fluorescent Protein product line that is based on technology licensed from Los Alamos National Laboratory (LANL).

March 2012 – Entered into an agreement with Interchim of France to distribute Sandia Biotech’s products in France and Europe.

June 2011 – Entered into a license agreement with Los Alamos National Laboratory (LANL) to produce, manufacture, and sell protein analysis kits based on Split Fluorescent Protein Technology developed by Dr. Geoffrey Waldo’s laboratory at LANL.

SandiaBio News Page

February 2023— Superfolder GFP & Split GFP - Sandia Biotech - Protein Folding Assay - Protein Analysis webinar .

June 2022—Attended BIO International 2022  with the New Mexico Pavilion to showcase innovative FluorAbody technology joint with Etaluma (a California company who has commercialized a state-of-the-art digital microscope platform).

April 2021–Collaborated with SciVista  (Virtual reality company) and Los Alamos National Laboratory in leverage project.

January 2021— “Systemic Creation of Fluorescent Fusion Polypeptides” Patent granted.

January 2021 – FluorAbodies are tested in live-cell imaging with  Confocal.nl’s  Re-scan Confocal Microscope Technology Platform. Look at our anti-Her2-RFP FluorAbody in action here.

April 2019 – NMSBA assistantship through Sandia National Laboratories

March 2017– NMSBA assistantship through Sandia National Laboratories

March 2016 – NMSBA assistantship through Sandia National Laboratories

February 2016 – Purchased the assets of Azano Scientific which includes a license to G protein estrogen receptor (GPER) compounds from STC.UNM and NMSU.

May 2015 – Entered agreement with Funakoshi of Japan as a distributor for Asia-Pacific.

October 2015 – Entered into a world-wide exclusive license agreement with STC.UNM which leads to the further development of an efficient and proprietary manufacturing process of FluorAbody® technology ( fluorescent antibody analogues) with intellectual property covered by several patents.

February 2015 – Entered into a co-distribution agreement with Azano Pharmaceuticals, Inc. of Albuquerque, NM.

September 2013 – Entered into a global distribution agreement with Sigma-Aldrich for Sandia Biotech’s Split Green Fluorescent Protein product line that is based on technology licensed from Los Alamos National Laboratory (LANL).

March 2012 – Entered into an agreement with Interchim of France to distribute Sandia Biotech’s products in France and Europe.

June 2011 – Entered into a license agreement with Los Alamos National Laboratory (LANL) to produce, manufacture, and sell protein analysis kits based on Split Fluorescent Protein Technology developed by Dr. Geoffrey Waldo’s laboratory at LANL.